Physician

Charles B Idom, M.D., FACS

According to 2025 Medicare claims, Charles Idom, M.D., FACS (NPI: 1316943210) practices urology in the Dalton, GA market, with the plurality of this provider's patient population coming from Whitfield, GA. This provider's primary affiliated billing organization is NORTH GEORGIA UROLOGY CENTER, PC, INC (NPI: 1861413197; TIN: 58-2650795) and primary practice location at 30720-3009.

Idom's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 691 traditional Medicare patients, billed 21,515 HCPCS/CPT codes, and received $719,426 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,327 prescription claims across 363 beneficiaries totaling $2,974,016 in drug costs, led by Xtandi (Enzalutamide). 2022 DME data shows 12 claims. Open Payments data shows 51 records totaling $1,229. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $774,832 and ending at $719,426. Concurrently, Part D prescription costs have risen steadily, from $131,086 to $2,974,016. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $304 and ending at $255.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	861	22,606	$774,832
2016	1,012	31,384	$515,074
2017	1,095	43,961	$680,711
2018	908	41,291	$555,560
2019	788	49,245	$524,877
2020	789	56,910	$687,996
2021	798	60,823	$1,075,069
2022	838	49,564	$729,842
2023	721	29,491	$670,304
2024	691	21,515	$719,426

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	479	2,258	$131,086
2016	454	1,997	$252,996
2017	428	1,759	$182,180
2018	442	1,590	$610,569
2019	386	1,336	$1,382,319
2020	336	1,210	$2,137,603
2021	367	1,277	$2,843,561
2022	366	1,293	$3,076,125
2023	404	1,511	$3,389,328
2024	363	1,327	$2,974,016

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	59	$6,543
2016	11	62	$10,999
2017	11	82	$12,073
2018	N/R	68	$8,938
2019	N/R	59	$8,212
2020	N/R	25	$7,332
2021	N/R	17	$4,151
2022	N/R	12	$15,188
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	274	408	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	420	668	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	292	453	$12
36415	Insertion of needle into vein for collection of blood sample	270	421	$9
81000	Manual urinalysis test with examination using microscope, non-automated	507	916	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	120	3,600	$1,670,816
Orgovyx	Relugolix	151	4,530	$391,391
Lynparza	Olaparib	22	660	$360,141
Nubeqa	Darolutamide	24	720	$317,516
Myrbetriq	Mirabegron	50	2,670	$39,951

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$1,229	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles B. Idom, M.D., FACS?

Tedicare shows public-source Medicare data for Charles B. Idom, M.D., FACS (NPI 1316943210), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles B. Idom, M.D., FACS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles B. Idom, M.D., FACS?

Charles B. Idom, M.D., FACS is linked to NORTH GEORGIA UROLOGY CENTER, PC, INC (billing NPI 1861413197) in the available physician profile data.

Does Charles B. Idom, M.D., FACS have Open Payments data?

Charles B. Idom, M.D., FACS has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.